Literature DB >> 26932673

Robust derivation of epicardium and its differentiated smooth muscle cell progeny from human pluripotent stem cells.

Dharini Iyer, Laure Gambardella, William G Bernard, Felipe Serrano, Victoria L Mascetti, Roger A Pedersen, Sanjay Sinha, Amarnath Talasila.   

Abstract

Entities:  

Year:  2016        PMID： 26932673      PMCID： PMC4813345          DOI： 10.1242/dev.136143

Source DB:  PubMed          Journal:  Development        ISSN： 0950-1991            Impact factor:   6.868


× No keyword cloud information.
  12 in total

1.  Pluripotent Stem Cells for Cell Therapy.

Authors:  Insa S Schroeder
Journal:  Methods Mol Biol       Date:  2021

2.  Stem cell therapy of myocardial infarction: a promising opportunity in bioengineering.

Authors:  Bin Jiang; Li Yan; James G Shamul; Maxwell Hakun; Xiaoming He
Journal:  Adv Ther (Weinh)       Date:  2020-02-03

3.  Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis.

Authors:  Hao Zhang; Lei Tian; Mengcheng Shen; Chengyi Tu; Haodi Wu; Mingxia Gu; David T Paik; Joseph C Wu
Journal:  Circ Res       Date:  2019-07-10       Impact factor: 17.367

4.  The extracellular matrix protein agrin is essential for epicardial epithelial-to-mesenchymal transition during heart development.

Authors:  Xin Sun; Sophia Malandraki-Miller; Tahnee Kennedy; Elad Bassat; Konstantinos Klaourakis; Jia Zhao; Elisabetta Gamen; Joaquim Miguel Vieira; Eldad Tzahor; Paul R Riley
Journal:  Development       Date:  2021-05-10       Impact factor: 6.868

5.  Engineered Microenvironment for Manufacturing Human Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells.

Authors:  Haishuang Lin; Xuefeng Qiu; Qian Du; Qiang Li; Ou Wang; Leonard Akert; Zhanqi Wang; Dirk Anderson; Kan Liu; Linxia Gu; Chi Zhang; Yuguo Lei
Journal:  Stem Cell Reports       Date:  2018-12-06       Impact factor: 7.765

Review 6.  Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures.

Authors:  Claudia Sacchetto; Libero Vitiello; Leon J de Windt; Alessandra Rampazzo; Martina Calore
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

Review 7.  Engineering Scalable Manufacturing of High-Quality Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Repair.

Authors:  Kaitlin K Dunn; Sean P Palecek
Journal:  Front Med (Lausanne)       Date:  2018-04-24

8.  Wnt inhibition promotes vascular specification of embryonic cardiac progenitors.

Authors:  David E Reichman; Laura Park; Limor Man; David Redmond; Kenny Chao; Richard P Harvey; Makoto M Taketo; Zev Rosenwaks; Daylon James
Journal:  Development       Date:  2018-01-08       Impact factor: 6.868

9.  CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy.

Authors:  Diogo Mosqueira; Ingra Mannhardt; Jamie R Bhagwan; Katarzyna Lis-Slimak; Puspita Katili; Elizabeth Scott; Mustafa Hassan; Maksymilian Prondzynski; Stephen C Harmer; Andrew Tinker; James G W Smith; Lucie Carrier; Philip M Williams; Daniel Gaffney; Thomas Eschenhagen; Arne Hansen; Chris Denning
Journal:  Eur Heart J       Date:  2018-11-14       Impact factor: 29.983

10.  A Novel Human Pluripotent Stem Cell-Derived Neural Crest Model of Treacher Collins Syndrome Shows Defects in Cell Death and Migration.

Authors:  Felipe Serrano; William George Bernard; Alessandra Granata; Dharini Iyer; Ben Steventon; Matthew Kim; Ludovic Vallier; Laure Gambardella; Sanjay Sinha
Journal:  Stem Cells Dev       Date:  2018-12-18       Impact factor: 3.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.